

Cardiac Drug Balloon Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Cardiac Drug Balloon market is experiencing significant growth due to increasing cardiovascular diseases and advancements in drug-eluting technology. The global market size was valued at approximately $1.2 billion in 2023, driven by rising demand for minimally invasive procedures and innovative therapeutic solutions. Market conditions reflect a trend toward personalized medicine.
◍ Boston Scientifc
◍ Medtronic
◍ AR BALTIC
◍ BD
◍ B. Braun Melsungen
◍ Koninklijke Philips
◍ Boston Scientific
◍ Opto Circuits
◍ AR Baltic Medical
◍ Acrostak
◍ Grandpharma (China) Co., Ltd.
◍ Yinyi(liaoning)Biotech CO.,LTD.
◍ Acotec Scientific Holdings Limited
◍ Lutonix
◍ Medrad
◍ Biotronik
◍ Eurocor GmbH
The Cardiac Drug Balloon Market is competitive, featuring players like Boston Scientific and Medtronic, which innovate and expand product portfolios. They enhance market growth through strategic partnerships and advancements. Sales revenue figures include:
- Boston Scientific: Approximately $11 billion
- Medtronic: Around $30 billion
- BD: About $20 billion
Overall, these companies drive innovation and market expansion.
Request Sample Report
Hospital
Cardiac Catheterization Laboratory
Cardiac Glycosides
Non-glycosides
Request Sample Report
Request Sample Report
$ X Billion USD